Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
NCT05320627Phase 4Completed
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Mar 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in nonvalvular atrial fibrillation (NVAF), sponsored by National Center for Cardiovascular Disease. Started Mar 2022; status: completed.
02
Drugs
edoxaban
03
Conditions
nonvalvular atrial fibrillation (NVAF)
Beyond the preview
Go deeper on NCT05320627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320627.